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Abstract
Objectives: To develop and evaluate the psychometric properties of a Chinese questionnaire which assesses the barriers
and enablers to commencing insulin in primary care patients with poorly controlled Type 2 diabetes.
Research Design and Method: Questionnaire items were identified using literature review. Content validation was
performed and items were further refined using an expert panel. Following translation, back translation and cognitive
debriefing, the translated Chinese questionnaire was piloted on target patients. Exploratory factor analysis and item-scale
correlations were performed to test the construct validity of the subscales and items. Internal reliability was tested by
Cronbach’s alpha.
Results: Twenty-seven identified items underwent content validation, translation and cognitive debriefing. The translated
questionnaire was piloted on 303 insulin naı¨ve (never taken insulin) Type 2 diabetes patients recruited from 10 government-
funded primary care clinics across Hong Kong. Sufficient variability in the dataset for factor analysis was confirmed by
Bartlett’s Test of Sphericity (P,0.001). Using exploratory factor analysis with varimax rotation, 10 factors were generated
onto which 26 items loaded with loading scores . 0.4 and Eigenvalues .1. Total variance for the 10 factors was 66.22%.
Kaiser-Meyer-Olkin measure was 0.725. Cronbach’s alpha coefficients for the first four factors were$0.6 identifying four sub-
scales to which 13 items correlated. Remaining sub-scales and items with poor internal reliability were deleted. The final 13-
item instrument had a four scale structure addressing: ‘Self-image and stigmatization’; ‘Factors promoting self-efficacy; ‘Fear
of pain or needles’; and ‘Time and family support’.
Conclusion: The Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) appears to be a reliable and valid measure for
assessing barriers to starting insulin. This short instrument is easy to administer and may be used by healthcare providers
and researchers as an assessment tool for Chinese diabetic primary care patients, including the elderly, who are unwilling to
start insulin.
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Introduction
The global burden of diabetes mellitus is rapidly increasing and
it is estimated that worldwide, over 285 million adults now suffer
from Type 2 diabetes mellitus (T2DM) [1]. T2DM is a metabolic
condition characterised by insulin resistance causing reduced
responsiveness to the effect of insulin on peripheral tissues,
resulting in high blood sugar levels. Insufficient insulin secretion
to overcome insulin resistance is also a feature of the condition.
T2DM has become a major public health problem in the Chinese,
with prevalence rates in China rising sharply in the past decade to
approximately 9.7% (accounting for approximately 92.4 million
adults) [2]. Located on the Pearl River Delta, Hong Kong is a
Special Administrative Region of the People’s Republic of China,
with a population which is over 95% ethnically Chinese.
Prevalence estimates for T2DM in Hong Kong adults range from
2% in people aged , 35 years to over 20% in those . 65 years
[3,4].
A significant proportion of T2DM is managed in primary care.
Hong Kong has a pluralistic health care economy and primary
care is provided by both private and public healthcare providers.
Government-funded general out-patient clinics provide approxi-
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mately 15% of all primary care consultations in Hong Kong,
focussing mainly on servicing the elderly and those with chronic
disease such as diabetes [5].
Several large studies, including the United Kingdom Prospec-
tive Diabetes Study (UKPDS), have demonstrated a strong
correlation over time between blood glucose control and
development of diabetic complications such as kidney failure,
blindness, leg amputations, cardiovascular diseases and stroke in
patients with T2DM [6–8]. Unfortunately, glycaemic control for
many T2DM patients worldwide remains sub-optimal which
predisposes them to a higher risk of complications and poor health
outcomes [9,10]. Many patients with T2DM are treated with oral
medications to help control blood glucose levels. These are taken
either alone or in combination, and work by correcting one or
more of the metabolic abnormalities which characterise the disease
(insulin deficiency, insulin resistance and increased hepatic glucose
output) [11]. Monitoring of blood glucose control is usually
performed by measuring levels of Haemoglobin A1C (HbA1C)
with levels. 7.0 indicating poor control [12]. Better blood glucose
control is usually achieved by ‘stepping up’ anti-diabetic
treatments through increasing oral therapy, or commencing
insulin [12]. Due to the progressive nature of T2DM, insulin
therapy is eventually indicated for many patients once maximal
doses of oral medications are no longer sufficient to control blood
sugar levels (‘failed oral therapy’) [12].
Notwithstanding that insulin is a safe and effective drug for
achieving glycaemic control [13,14], it is a global phenomenon
that most T2DM patients resist starting insulin, predominantly
because of psychological reasons (termed ‘psychological insulin
resistance’) [15–22]. The decision to start insulin is often difficult
and patients’ reluctance may cause delays in initiating therapy,
prolonging their sub-optimal glycaemic control [19]. Unwilling-
ness or refusal to start insulin has been found to be more common
in Chinese patients. Studies conducted in Chinese populations
report over 70% of T2DM patients are unwilling to start insulin
[23], which is higher than in non-Chinese patients where reported
resistance or refusal rates have ranged from 28.2% to 46.6%
[20,24,25].
Reluctance to commence insulin may be a result of a range of
personal viewpoints involving cognitive appraisal or emotional
reactions [26], which can be influenced by culture [27–29], degree
of self-efficacy and health literacy [30]. Chinese patients appear to
be more concerned about the psycho-social aspects of insulin
treatment such as impact on self-image, social stigmatization, or
inability to acquire the necessary skills, than the physical aspects
such as having a hypoglycaemic attack or weight gain [26,27,31].
A number of questionnaires have been developed which assess
patient attitudes towards insulin therapy [32–34] including the
Chinese version Insulin Treatment Appraisal Scale (ITAS) [31],
however none have been designed or validated for use in
predominantly elderly primary care patients who have not yet
started insulin therapy (referred to as ‘insulin naı¨ve’ patients).
Having an instrument which easily identifies the patients’ reasons
for refusing insulin would be a valuable assessment tool for
healthcare providers enabling them to more effectively tailor
educational interventions to help overcome their concerns.
As there was no suitable assessment tool available, the aim of
this study was to develop and validate a Chinese questionnaire
which assesses the barriers and enablers to starting insulin
treatment in insulin naı¨ve T2DM patients with the following
objectives:
1. To identify relevant items which can be used to assess patient
attitudes regarding starting insulin
2. To translate the items into Chinese.
3. To pilot the developed instrument on a primary care
population to assess acceptability and feasibility of administer-
ing the questionnaire to elderly patients with T2DM.
4. To assess the psychometric properties of the translated
instrument.
Methods
The Research Ethics Committee of the Kowloon West Cluster,
Hospital Authority of Hong Kong granted research ethics
approval of the research protocol.
Instrument Development
Twenty-seven potential items were originally identified. Twen-
ty-six were derived from literature review (Table 1) with a further
one item derived from a pilot study conducted on local T2DM
patients [35]. A six-person expert panel of health care providers
(comprised of 4 primary care doctors, 1 endocrinologist and 1
nurse specialized in diabetes care) were invited to review the items
for content, breadth, and relevancy and to rate each item on
validity, relevance. A content validity index (CVI) was calculated
Table 2. Sociodemographic and Clinical Characteristics of
Type 2 Diabetes Patients at Baseline.
Characteristics Total (N=303)
Sociodemographic
Age (median year, IQR) 63 (54–70)
Gender (%)
Male 136 (44.9%)
Female 167 (55.1%)
Education (%)
No formal education 44 (15.4%)
Primary 117 (41.1%)
Secondary 107 (37.5%)
Tertiary 17 (6.0%)
Occupation (%)
Full time work 90 (32.8%)
Unemployed/retired 82 (29.9%)
Housewife 99 (36.1%)
Part time 3 (1.1%)
Mode of Administration (%)
Self 104 (34.4%)
Interviewer 189 (62.6%)
Clinical
Duration of DM (median year, IQR) 11 (7–16)
Last HbA1c Level (median %, IQR) 8.3 (7.9–9.1)
Hypertension (%) 246 (81.2%)
DM drug (%)
Glibenclamide 37 (12.2%)
Gliclazide 259 (85.5%)
Metformin 303 (100.0%)
Note: IQR, Interquartile range.
doi:10.1371/journal.pone.0078933.t002
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for each item. Items scoring$ 80% were retained [36]. Items with
CVI ,80% were eliminated or revised. The items were then
formatted to create a structured English questionnaire with a four-
point Likert scale response option for each item (from Strongly
Agree to Strongly Disagree).
The questionnaire was translated into Chinese by the principal
investigator (SF) and translated back into English by another co-
investigator (MY) to assess translational equivalence. Discrepancies
between the original English items and back-translated items were
reviewed by both investigators. All nonequivalent items were
modified to enhance their translational equivalence to the original
English version. Both investigators are bilingual with previous
experience in translation of questionnaire surveys. The resulting
Chinese instrument underwent field testing and cognitive debrief-
ing interviews using 10 patients with different distributions of age,
sex, and previous insulin use.
Pilot psychometric testing of the Ch-ASIQ
The 27 item Chinese Attitudes to Starting Insulin Questionnaire
(Ch-ASIQ) was pilot-tested on primary care patients recruited
from ten Hospital Authority primary care clinics across Hong
Kong. All eligible patients attending any of the study locations
during the study period were invited to participate. Eligible
subjects were identified through the Hospital Authority’s computer
dispensing system and invited to complete the questionnaire when
they attended the clinic for a scheduled follow-up appointment. As
a large proportion of patients attending these clinics are elderly
with low literacy levels, trained research assistants helped to
explain the study, obtain signed consent and administered the
questionnaires.
All eligible subjects were consecutively recruited until the
required sample size was reached. Sample size calculation was
based on the number needed to perform the factor analysis for
psychometric assessment of the instrument. As there were 27
potential items, based on the subject to item ratio of 10:1 [37], a
sample size of 270 subjects was required. Inclusion criteria were:
Chinese-speaking adults aged $18 or #80; on maximum
recommended or maximum tolerable doses of oral diabetic
medications (Gliclazide 320 mg, Gliclazide modified release
120 mg, or Glibenclamide 15 mg and metformin $2 g daily) ;
most recent HbA1c level $7.5% within past 12 months indicating
insufficient glycaemic control [6,12]. Exclusion criteria included:
pregnancy; unable to answer a questionnaire due to mental
incapacity; or already on insulin therapy.
Statistical Analysis
Descriptive statistics were calculated with median and inter-
quartile ranges (IR) for continuous variables, and frequency and
proportion for categorical variables. Negative items were re-coded
and responses scored from one to four with higher scores
indicating more positive attitudes. Exploratory factor analysis
(EFA) was used to explore the underlying structure of the
instrument and to sort items into sub-scales. A factor loading
score $0.4 was used to sort items into factors. Items which cross-
loaded across two factors, and one-item factors were deleted. The
Kaiser–Meyer–Olkin (KMO) measure of sampling adequacy
(using a cut-off of 0.5), and Barlett’s Test of Sphericity (using a
cut-off P,0.001) was used to ensure the appropriateness of the
data set for EFA. Cronbach’s alpha coefficient was used to assess
the internal reliability of each sub-scale identified by EFA. A
Cronbach’s alpha coefficient $ 0.6 was used as the cut-off to
indicate sufficient internal reliability [37].T
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Table 4. Mean scores and distribution of responses to individual items, and Internal consistency for each scale.
Scale/individual item Mean±SD
Agree/Totally
Agree (%)
Cronbach’s alpha
if item deleted
Scale 1: Self image and stigmatization (Cronbach’s alpha = 0.802)
Item #22 I worry that people will know I have diabetes if I am on insulin treatment 2.3660.85 121 (40.33%) 0.702
Item #23 Injecting insulin is embarrassing, I worry about being seen when I
inject insulin
2.4960.81 147 (49.16%) 0.663
Item #24 If I have to inject insulin, it makes me feel like drug addicts 2.4560.80 133 (44.93%) 0.812
Scale 2: Factors promoting self-efficacy (Cronbach’s alpha = 0.675)
Item #01 I have up-to date knowledge about diabetes management 2.6060.83 189 (63.21%) 0.670
Item #08 Insulin can help control blood glucose and prevent complications 2.6560.68 181 (63.73%) 0.618
Item #14 I can manage the skill of injecting insulin 2.7260.75 201 (67.45%) 0.592
Item #26 There is social support available if I have to inject insulin 2.3760.68 131 (44.41%) 0.601
Item #27 I can pay as close attention to my diet as insulin treatment requires.
For example, I may need to take snack or reduce eating amount
appropriately according
2.6760.66 196 (66.67%) 0.640
Scale 3: Fear of pain or needles (Cronbach’s alpha = 0.653)
Item #13 Injecting insulin is painful 2.7960.73 200 (66.89%) 0.620
Item #16 I am afraid of needle injections 2.9160.86 211 (70.57%) 0.340
Item #17 I worry about needing to perform home blood sugar monitoring 2.5960.82 158 (53.02%) 0.656
Scale 4: Time & family support(Cronbach’s alpha = 0.620)
Item #20 I can spare enough time to perform insulin injection 2.5860.71 176 (59.46%) NA
Item #25 My family will support me to inject insulin 2.4560.73 133 (45.70%) NA
Scale 5: Misunderstanding of insulin therapy (Cronbach’s alpha = 0.573)
Item #06 Insulin can cause permanent damage or worsening of
my health.
2.5060.71 133 (45.86%) 0.512
Item #09 Diabetes tablets work better than insulin 2.8260.70 205 (69.26%) 0.460
Item #10 Insulin injection means failure of the diabetes tablet treatment 2.7360.64 197 (66.55%) 0.560
Item #15 Injecting insulin is inconvenient 3.0560.72 242 (80.40%) 0.463
Scale 6: Worry about complications of insulin therapy (Cronbach’s alpha = 0.488)
Item #05 Insulin treatment for diabetes causes feelings of drug dependence. 2.6360.69 172 (58.70%) 0.550
Item #11 An insulin overdose can lead to extremely low blood-sugar levels
("hypoglycemia"). I am afraid of experiencing the symptoms of low
blood sugar levels
2.6160.68 168 (57.53%) 0.337
Item #12 I worry about weight gain associated with insulin injections 2.4060.65 117 (39.80%) 0.374
Item #18 I worry about skin marks or skin complications associated with
injecting insulin
2.5660.72 152 (51.18%) 0.383
Item #21 Insulin treatment will make life less flexible, affect my social life and
hobbies (e.g. performing exercise, dinning outside)
2.6760.73 174 (58.78%) 0.485
Scale 7: Trust in health care professionals (Cronbach’s alpha = 0.203)
Item #02 I trust that my doctor is providing me with the most appropriate diabetes
management for me
3.2260.60 278 (92.67%) NA
Item #03 I wish to or I am now trying Traditional Chinese Medicine to control
blood sugar
2.3560.79 130 (43.05%) NA
Item #04 I wish to or am now trying lifestyle (diet control and exercise) or other
alternative medicine (e.g. complementary medicine, Qi Kung, etc) to
control blood sugar
3.1560.58 280 (92.72%) NA
Note:
NA = Not applicable due to small number of items.
doi:10.1371/journal.pone.0078933.t004
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IBM SPSS Statistics for Windows, Version 20.0 statistical
software was used to conduct descriptive and exploratory factor
analyses.
Results
Twenty-seven items (Table 1) underwent content validation.
The calculated CVI of all items scored . 80% for all items and
were retained. All items on cognitive debriefing also yielded scores
. 80%. (Table 1)
306 eligible subjects were approached and 303 subjects
completed the questionnaire (response rate = 99%). The socio-
demographic and clinical characteristics of the subjects are shown
in Table 2. Typical of the patient population attending govern-
ment-funded primary care clinics, subjects were elderly, had lower
levels of education, and only one third were in full-time
employment. The median duration of T2DM was 11 years (IR
= 7 to 16 years) and median HbA1c level was HbA1c level 8.3%
(IR = 7.9 to 9.1%) indicating very poor levels of glycaemic
control.
Using the principal component EFA with varimax rotation, ten
factors with eigenvalues $1 were extracted as shown in Table 3.
The KMO measure was 0.725 indicating sampling adequacy.
Sufficient variability in the data was confirmed by Bartlett’s Test of
Sphericity (P,0.001) confirming the validity of data available for
EFA. The ten factors, onto which 26 items with the absolute
magnitude of factor loadings exceeded 0.4, explained 66.22% of
the total variation. Item 7 was itself regarded as a one-item factor,
and was dropped for subsequent analysis. No items cross-loaded
over more than one factor.
For ease of clinical interpretation, the remaining nine factors
(excluding the tenth factor with eigenvalue marginally greater than
one) were collapsed to seven sub-scales. The descriptive scores and
the proportion of subjects rating ‘agree’ or ‘strongly agree’ for each
item according to sub-scale categorisation, with the Cronbach’s
alpha coefficient of each sub- scale is shown in Table 4. Sub-scale
(6) interpreted as ‘Worry about complications of insulin therapy’
was the combination of factor 6 and factor 8, whereas sub-scale (7),
interpreted as ‘Trust in health professionals’, was the combination
of factor 7 and factor 9. Internal consistency of the seven sub-scales
was assessed using the Cronbach’s alpha. Four of the sub-scales
had Cronbach’s alpha values .0.6 indicating sufficient internal
consistency. The remaining sub-scales had poor internal consis-
tency and those items were removed.
The final instrument yielded 13 items with four sub-scales
(Appendix S1 and Appendix S2(Chinese Version)) which were
interpreted as (1) ‘Self-image and stigmatization’; (2) ‘Factors
promoting self-efficacy’ (3) ‘Fear of pain or needles’; and (4) ‘Time
& family support’.
Discussion
This is the first report describing the development and
psychometric validation of a Chinese questionnaire that assesses
barriers and enablers to starting insulin therapy in insulin naı¨ve
T2DM primary care patients. The instrument is based on
translations and adaptation of six different questionnaires
[19,32–34,38,39] and literature reviews (Table 1) and has
undergone assessment for translational equivalence, and content
validation to ensure items are appropriate for application to
Chinese primary care patients. The questionnaire was able to be
understood by both males and females of varying ages including
elderly patients and those with lower educational levels. The
questionnaire was understood by patients who had and had not
previously used insulin.
Consistent with other psychometric validated questionnaires
[32–34], the Ch-ASIQ contained two subscales which measured
two common psychological barriers to insulin treatment: stigma
of insulin use and fear of injections. Insulin therapy is commonly
associated with negative connotations and often causes dysfunc-
tional emotions such as fear, anxiety [26]. In clinical practice
clinicians need to take into consideration their patients’ negative
emotions and concerns when they counsel patients about the
need to start insulin. It is therefore appropriate that items
addressing these issues should be included in a clinical assessment
tool. Similarly, the Ch-ASIQ contained two subscales which
measured the patient’s perceived needs in terms of personal
resources required to take on the added responsibility of insulin
therapy. In clinical practice, it is also important to identify ways
to empower patients so that they can better look after their health
and an assessment of needs in terms of knowledge, skills, social
support and time should be factored into an evaluation of an
individual’s readiness to adhere to any changes in drug regimen
[40].
Although components of social and family support are rarely
mentioned in other questionnaires, it appears to be quite
important for Chinese patient populations. Family engagement
is important in Chinese culture and there appears to be a
correlation between the amount of perceived family support and
health behaviors in Chinese patients with chronic diseases, in
particular, those who are elderly [26,35,38,41]. Such support is
also important for patients with lower education levels and lower
health literacy as they may require additional assistance to follow
the instructions of a new prescription [30].
Time appears to be an important factor in our setting. Despite
the fact that less than one third of the tested subjects were in full-
time employment, time was still considered consistently an
essential item in the subscale relating to personal resources. This
likely reflects the culture of Hong Kong society as its citizens live in
one of the fastest paced countries in the world [42], have long
working hours, and have limited free time [43].
The deleted items from the sub-scales with low Cronbach’s
alpha coefficients reflect values and attitudes which are less
significant and less consistently considered in our setting. Items
within the sub-scales interpreted as ‘Misunderstanding of insulin
therapy’; ‘Worry about complication of insulin therapy’; ‘Trust in
health care professionals’ appear to be less important in our study
population possibly due to their lower levels of education, age,
and ethnicity. Chinese elderly patients appear to be less likely to
question the doctor’s expertise or advice [44].
The items related to fear of hypoglycemia, weight gain and
complications of insulin which appear to be important in other
studies [17,18,20,21,23,27,30,32–34] were not consistently
weighted in the exploratory factor analysis of this study
population. Similar findings were also found in another study
interviewing Chinese subjects [27]. One explanation is that the
anxiety evoked by injections far exceeds the anxiety evoked by
any other factor.
Other studies have hypothesized that one reason for insulin
refusal is that Chinese patients might not trust Western Medicine
[27]. However, in this study, the items related to distrust of
Western medicine were also deleted, reflecting that these were not
major and consistent barriers among our target subjects.
There were a number of limitations to this study. The
questionnaires were interviewer-administered in majority of the
Attitudes to Insulin Questionnaire (Ch-ASIQ)
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subjects as our patient population has poor literacy levels. It is
possible that the Ch-ASIQ’s psychometrics may differ if self-
administered. We chose to keep only those items that
demonstrated a clear and unambiguous factor loading and
some of the items that were excluded after factor analyses may
still be relevant for patients in other settings. Test-retest
reliability was not been performed and further studies to
examine the responsiveness of the instrument (ability to detect
change) following intervention or over time are still required.
Conclusion
The 13-item Chinese Attitudes to Starting Insulin Question-
naire (Ch-ASIQ) offers reliable psychometric properties as well as
an interpretable and relevant structure. Our findings suggest that
the Ch-ASIQ can be used by clinicians and researchers in a valid
and reliable way to assess and address psychological barriers to
insulin treatment in Chinese T2DM subjects in primary care
setting. The future application of this instrument will be to guide
the development of tailored education interventions to help these
patients accept and initiate insulin therapy, and to assess the
outcomes of the interventions.
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